Helminth Infection During Pregnancy on Vitamin D Regulation: HELMVIT Study
Study Details
Study Description
Brief Summary
Purpose: To examine whether helminth infection during pregnancy alters Vitamin-D-metabolism and reactivity of the child's immune system
Hypothesis: Helminth infection during pregnancy is associated with altered Vitamin D levels and Vitamin D receptor expression in the placenta and modified immune reactivity in the infant.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Objectives The primary objective of the proposed research project is to study the impact of helminth infection in general and particularly of infection with S. haematobium during pregnancy on Vitamin D metabolism and its related factors as well as the impact of maternal infection on infants developing immune system and health.
Specific Objectives To assess the effect of maternal helminths infections on Vitamin D and vitamin-D-related factors in the serum of pregnant women and cord blood of their infants,
To assess the effect of helminth infection on placental biology:
Determine expression levels of VDR and inflammatory genes Investigate histologically the gestational age and other functional aspects of the placenta Determine the influence of helminth driven inflammation and helminth antigens on placental tissue by establishing a (co-)culture system using primary placental cells and a placental cell line To assess whether helminth infections influence the infant's peripheral immune system by analyzing composition, reactivity and lineage determination of fetal cord blood mononuclear cells (CBMCs) in relation to the maternal and fetal immune and Vitamin D status.
Current study focusing objectives In the present study the investigators explore if and how Vitamin D and its related signals are modulated by helminth infection and how helminth infection could thereby shape the developing immune system of the newborn by analyzing CBMCs.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
S. haematobium positive Preganant women infected with Schistosomia hematobium alone |
Diagnostic Test: Microscopy ( Urine filtration), UCAA test, qPCR,
Schistosomiasis is an acute and chronic parasitic disease caused by blood flukes (trematode worms) of the genus Schistosoma.Schistosomiasis is prevalent in tropical and subtropical areas, especially in poor communities without access to safe drinking water and adequate sanitation.
|
geohelminths positive pregnant women infected with geohlminths alone |
Diagnostic Test: Microscopy (Kato Katz, Coproculture, Harada Mori, MIF), qPCR,
Soil-transmitted helminth infections are among the most common infections worldwide and affect the poorest and most deprived communities. They are transmitted by eggs present in human faeces which in turn contaminate soil in areas where sanitation is poor.
|
Helminth negative Pregnant women free of anyn helminths infection |
Diagnostic Test: Microscopy (Kato Katz, Coproculture, Harada Mori, MIF), qPCR,
Soil-transmitted helminth infections are among the most common infections worldwide and affect the poorest and most deprived communities. They are transmitted by eggs present in human faeces which in turn contaminate soil in areas where sanitation is poor.
|
Outcome Measures
Primary Outcome Measures
- Association between Schistosoma and helminth infection and Vitamin D levels. [48 Months]
Schistosoma hematobium in preganancy is associated with vitamin D metabolism
Secondary Outcome Measures
- Association between Schistosoma infection and intrauterine growth restriction (IUGR) (defined as birth weight below the 10th birth weight percentile), stillbirth and premature delivery. [48 Months]
Schistosoma hematobium infection during pregnancy is associated with a birth weight born child
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Pregnant women attending antenatal care from Lambaréné and Fougamou areas
-
Pregnant women who have given written informed consent to the study for herself and for her unborn child and live infant.
Exclusion Criteria:
- Known of chronic infections and diseases(e.g. diabetes, HIV, Hepatitis B and C, anemia).
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Josiane Y Honkpehedji | Lambaréné | Moyen Ogooué | Gabon | BP 242 |
Sponsors and Collaborators
- Centre de Recherche Médicale de Lambaréné
- Technische Universität München
- University Hospital Tuebingen
Investigators
- Principal Investigator: Ayola A ADEGNIKA, MD, PhD, Centre de Recherche Médicale de Lambaréné
- Study Chair: Meral Esen, MD, University Hospital Tuebingen
- Study Director: Clarissa DaCosta, MD, Technische Universität München
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- PROT N°038/2018/SG/CNE